Indian Pharmaceutical Industry Business Environment 3 Agenda • • • • • • • History Indian Pharmaceutical Evolution Facts and Figures Regulatory Framework Current ongoing activities SWOT Analysis The India Advantage 4 History • Bengal Chemicals and Pharmaceutical Works‚ Calcutta‚ the first Indian pharmaceutical company established in 1901 • Still exists as one of the 5 government owned drug manufacturers • Next 60 years saw most of the drugs imported from multinationals 5 History
Premium Pharmaceutical industry Pharmacology Clinical trial
eSectoral Survey Pharmaceutical Industry in Egypt November 2010 Sectoral survey: Pharmaceutical Industry Index Page 1. Introduction 2. Definition 3. Regulatory framework 3.1.Regulatory body 3.2.Pricing 3.3.TRIPS 3 4 4 4. Market analysis 4.1.Market structure 4.2.Consumption 4.3.Production 4.4.Key players 7 5. Trade 5.1.Exports 5.2.Imports 5.3.Balance of trade 9 6. SWOT analysis 7. Outlook 8. Recommendations 9. Conclusion Appendix References 11 12 13 13 2
Premium Pharmacology Generic drug Food and Drug Administration
Stringent government regulation and powerful purchaser pressures. • Governments focused on pharmaceuticals in efforts to control rising healthcare expenditure. • Inter-country pricing disparities. Economic • European free trade agreements. Social • Ageing populations create pressure on healthcare systems. • Epidemic or chronic diseases (e.g. obesity). Technological • Impact of genetic research on industry. • Utilizing a web of alliances to address multiple customer needs Environmental
Premium Generic drug Pharmaceutical industry Regulation
R&D and manufacturing facilities receive ISO 9001 certification from RWTUV‚ Germany 1994 Biocon establishes Syngene International Pvt. Ltd. as a Custom research Company (CRC) to address the growing need for outsourced R&D in the pharmaceutical sector 1996 The commercial success of Biocon’s proprietary fermentation plant leads to a 3-fold expansion Biocon leverages its technology platform to enter biopharmaceuticals and statins 1998 Unilever inks a deal with ICI to sell
Premium Pharmaceutical industry Marketing Pharmacology
Merck‚ being on one of the biggest pharmaceutical companies in the world today‚ came from a meek beginning and still encounters many problems today while trying to maintain a lead amongst its competition. While being looked at as a research and development driven company‚ Merck now has to go beyond R&D to stay competitive in the pharmaceutical industry. Attracting talent to work for the company has never been a problem for Merck‚ but the bigger question was whether or not this talent would be able
Premium Pharmaceutical industry Pharmacology Generic drug
1) PHARMACEUTICAL INDUSTRY ANALYSIS 1.1 Industry Background: The total industry can broadly be classified into two categories. Theses are a) Patent Medicines b) Generic Medicines Patent medicines are the products that are invented by the company‚ who have their own research team working on their own laboratories. These products are patented for many years to enjoy the monopoly market. After years of business the formulation is sold in the market so that others can go into mass production
Premium Pharmaceutical industry Pharmacology Patent
Today the pharmaceutical industry is one of the biggest industries in the United States. The industry experienced a rapid growth rate (in the double digits) in the late 20th century which has now dropped into the single digits (Mullins‚ 2007). The global demand is driven by factors such as a worldwide increase in elderly population and a rising quality of life in developing nations. Time Magazine listed Generic Pharmaceutical Manufacturing as one of the top ten fastest growing industries in the United
Premium Pharmacology Pharmaceutical industry Pharmacy
Jennifer Ambert Prof Weren Fall 12’ Tuesday 6p-8:40p MGT4600-61 Pfizer Case Study 1. Why has the pharmaceutical industry been so successful historically? The pharmaceutical industry has been such a successful industry for numerous reasons: • Patent protection is considered to be an incentive for investing‚ and also creates customer loyalty. • Generic brands have been profitable and cost efficient for buyers. This simply means that suppliers don’t need to offer a particular name brand;
Premium Pharmacology Brand Patent
1. Overview of the global pharmaceutical industry In 2003‚ Britain’s Guardian newspaper commented that‚ “on the face of it‚ the global pharmaceutical industry looks like the epitome of a modern‚ mature industry that has found a comfortable way to make profits by the billion: it ’s global‚ hi-tech‚ and has the ultimate customer‚ the healthcare budgets of the world ’s richest countries.” Guardian sept 2003 The global pharmaceutical industry is nowadays made up of thousands of companies contained
Premium Generic drug Pharmaceutical industry Pharmacology
Series I. 21. Bangladesh Bank (2006-2007) 24. Akhtar‚ S. (2006). “Address by the Governor of the State Bank of Pakistan” at the Pakistan Banking Association‚ London‚ 12 November 2006. 25. Reuters (2008) 26. The New Nation. (2008). “Rupali Bank dropped from privatisation list”. The New Nation Article on March 11‚ 2008. Available 27. http://nation.ittefaq.com/issues/2008/03/11/news0841.htm 28. International Energy Agency database of statistics on various countries available at http://www.iea.org/Textbase/stats/index
Premium Investment